Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates

Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibiti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2002-02, Vol.45 (4), p.753-757
Hauptverfasser: Remiszewski, Stacy W, Sambucetti, Lidia C, Atadja, Peter, Bair, Kenneth W, Cornell, Wendy D, Green, Michael A, Howell, Kobporn Lulu, Jung, Manfred, Kwon, Paul, Trogani, Nancy, Walker, Heather
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 757
container_issue 4
container_start_page 753
container_title Journal of medicinal chemistry
container_volume 45
creator Remiszewski, Stacy W
Sambucetti, Lidia C
Atadja, Peter
Bair, Kenneth W
Cornell, Wendy D
Green, Michael A
Howell, Kobporn Lulu
Jung, Manfred
Kwon, Paul
Trogani, Nancy
Walker, Heather
description Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibition assay, a p21waf1 (p21) promoter assay, and in monolayer growth inhibition assays. One compound, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, was found to affect the growth of a panel of eight human tumor cell lines differentially.
doi_str_mv 10.1021/jm015568c
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71440914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71440914</sourcerecordid><originalsourceid>FETCH-LOGICAL-a445t-e87532126829f1a22f0b8fd75e9de5f43fe9286e34565d3a174c8ad2511ba21e3</originalsourceid><addsrcrecordid>eNptkE1v00AQQFcIRNPCgT-AfAGpB5ed_bDX3KpQSFFVkFIkbquJPSYb_FF216jmxLV_s7-kLomaC6cZaZ6eRo-xV8BPgAt4t2k5aJ2Z8gmbgRY8VYarp2zGuRCpyIQ8YIchbDjnEoR8zg4AjARj8hkbzru1W7nY-5D0dbIYWuyShQux7yj5QFhSHBsM9P7u722yHLu4puBCgl2VnHV_xpb-rXNqmqFBn5yW0f12cXxwLaNH92Mdk_ka3SQdK9_fYIuRwgv2rMYm0MvdPGLfPp5dzRfpxZdP5_PTixSV0jElk2spQGRGFDWgEDVfmbrKNRUV6VrJmgphMpJKZ7qSCLkqDVZCA6xQAMkj9nbrvfb9r4FCtK0L5fQsdtQPweagFC9ATeDxFix9H4Kn2l5716IfLXD70Ng-Np7Y1zvpsGqp2pO7qBPwZgdgKLGpPXalC3tOKgMgzcSlW27KTTePd_Q_bZbLXNurr0urPl8qKC6_W7H3Yhnsph98N7X7z4P3GqCgCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71440914</pqid></control><display><type>article</type><title>Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Remiszewski, Stacy W ; Sambucetti, Lidia C ; Atadja, Peter ; Bair, Kenneth W ; Cornell, Wendy D ; Green, Michael A ; Howell, Kobporn Lulu ; Jung, Manfred ; Kwon, Paul ; Trogani, Nancy ; Walker, Heather</creator><creatorcontrib>Remiszewski, Stacy W ; Sambucetti, Lidia C ; Atadja, Peter ; Bair, Kenneth W ; Cornell, Wendy D ; Green, Michael A ; Howell, Kobporn Lulu ; Jung, Manfred ; Kwon, Paul ; Trogani, Nancy ; Walker, Heather</creatorcontrib><description>Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibition assay, a p21waf1 (p21) promoter assay, and in monolayer growth inhibition assays. One compound, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, was found to affect the growth of a panel of eight human tumor cell lines differentially.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm015568c</identifier><identifier>PMID: 11831887</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Benzamides - chemical synthesis ; Benzamides - chemistry ; Benzamides - pharmacology ; Biological and medical sciences ; Cyclin-Dependent Kinase Inhibitor p21 ; Cyclins - metabolism ; Drug Screening Assays, Antitumor ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; General aspects ; Histone Deacetylase Inhibitors ; Humans ; Hydroxamic Acids - chemical synthesis ; Hydroxamic Acids - chemistry ; Hydroxamic Acids - pharmacology ; Hydroxylamines - chemical synthesis ; Hydroxylamines - chemistry ; Hydroxylamines - pharmacology ; Medical sciences ; Models, Molecular ; Pharmacology. Drug treatments ; Promoter Regions, Genetic ; Structure-Activity Relationship ; Tumor Cells, Cultured</subject><ispartof>Journal of medicinal chemistry, 2002-02, Vol.45 (4), p.753-757</ispartof><rights>Copyright © 2002 American Chemical Society</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a445t-e87532126829f1a22f0b8fd75e9de5f43fe9286e34565d3a174c8ad2511ba21e3</citedby><cites>FETCH-LOGICAL-a445t-e87532126829f1a22f0b8fd75e9de5f43fe9286e34565d3a174c8ad2511ba21e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm015568c$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm015568c$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13481138$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11831887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Remiszewski, Stacy W</creatorcontrib><creatorcontrib>Sambucetti, Lidia C</creatorcontrib><creatorcontrib>Atadja, Peter</creatorcontrib><creatorcontrib>Bair, Kenneth W</creatorcontrib><creatorcontrib>Cornell, Wendy D</creatorcontrib><creatorcontrib>Green, Michael A</creatorcontrib><creatorcontrib>Howell, Kobporn Lulu</creatorcontrib><creatorcontrib>Jung, Manfred</creatorcontrib><creatorcontrib>Kwon, Paul</creatorcontrib><creatorcontrib>Trogani, Nancy</creatorcontrib><creatorcontrib>Walker, Heather</creatorcontrib><title>Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibition assay, a p21waf1 (p21) promoter assay, and in monolayer growth inhibition assays. One compound, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, was found to affect the growth of a panel of eight human tumor cell lines differentially.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Benzamides - chemical synthesis</subject><subject>Benzamides - chemistry</subject><subject>Benzamides - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cyclin-Dependent Kinase Inhibitor p21</subject><subject>Cyclins - metabolism</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>General aspects</subject><subject>Histone Deacetylase Inhibitors</subject><subject>Humans</subject><subject>Hydroxamic Acids - chemical synthesis</subject><subject>Hydroxamic Acids - chemistry</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Hydroxylamines - chemical synthesis</subject><subject>Hydroxylamines - chemistry</subject><subject>Hydroxylamines - pharmacology</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Pharmacology. Drug treatments</subject><subject>Promoter Regions, Genetic</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1v00AQQFcIRNPCgT-AfAGpB5ed_bDX3KpQSFFVkFIkbquJPSYb_FF216jmxLV_s7-kLomaC6cZaZ6eRo-xV8BPgAt4t2k5aJ2Z8gmbgRY8VYarp2zGuRCpyIQ8YIchbDjnEoR8zg4AjARj8hkbzru1W7nY-5D0dbIYWuyShQux7yj5QFhSHBsM9P7u722yHLu4puBCgl2VnHV_xpb-rXNqmqFBn5yW0f12cXxwLaNH92Mdk_ka3SQdK9_fYIuRwgv2rMYm0MvdPGLfPp5dzRfpxZdP5_PTixSV0jElk2spQGRGFDWgEDVfmbrKNRUV6VrJmgphMpJKZ7qSCLkqDVZCA6xQAMkj9nbrvfb9r4FCtK0L5fQsdtQPweagFC9ATeDxFix9H4Kn2l5716IfLXD70Ng-Np7Y1zvpsGqp2pO7qBPwZgdgKLGpPXalC3tOKgMgzcSlW27KTTePd_Q_bZbLXNurr0urPl8qKC6_W7H3Yhnsph98N7X7z4P3GqCgCg</recordid><startdate>20020214</startdate><enddate>20020214</enddate><creator>Remiszewski, Stacy W</creator><creator>Sambucetti, Lidia C</creator><creator>Atadja, Peter</creator><creator>Bair, Kenneth W</creator><creator>Cornell, Wendy D</creator><creator>Green, Michael A</creator><creator>Howell, Kobporn Lulu</creator><creator>Jung, Manfred</creator><creator>Kwon, Paul</creator><creator>Trogani, Nancy</creator><creator>Walker, Heather</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020214</creationdate><title>Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates</title><author>Remiszewski, Stacy W ; Sambucetti, Lidia C ; Atadja, Peter ; Bair, Kenneth W ; Cornell, Wendy D ; Green, Michael A ; Howell, Kobporn Lulu ; Jung, Manfred ; Kwon, Paul ; Trogani, Nancy ; Walker, Heather</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a445t-e87532126829f1a22f0b8fd75e9de5f43fe9286e34565d3a174c8ad2511ba21e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Benzamides - chemical synthesis</topic><topic>Benzamides - chemistry</topic><topic>Benzamides - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cyclin-Dependent Kinase Inhibitor p21</topic><topic>Cyclins - metabolism</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>General aspects</topic><topic>Histone Deacetylase Inhibitors</topic><topic>Humans</topic><topic>Hydroxamic Acids - chemical synthesis</topic><topic>Hydroxamic Acids - chemistry</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Hydroxylamines - chemical synthesis</topic><topic>Hydroxylamines - chemistry</topic><topic>Hydroxylamines - pharmacology</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Pharmacology. Drug treatments</topic><topic>Promoter Regions, Genetic</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Remiszewski, Stacy W</creatorcontrib><creatorcontrib>Sambucetti, Lidia C</creatorcontrib><creatorcontrib>Atadja, Peter</creatorcontrib><creatorcontrib>Bair, Kenneth W</creatorcontrib><creatorcontrib>Cornell, Wendy D</creatorcontrib><creatorcontrib>Green, Michael A</creatorcontrib><creatorcontrib>Howell, Kobporn Lulu</creatorcontrib><creatorcontrib>Jung, Manfred</creatorcontrib><creatorcontrib>Kwon, Paul</creatorcontrib><creatorcontrib>Trogani, Nancy</creatorcontrib><creatorcontrib>Walker, Heather</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Remiszewski, Stacy W</au><au>Sambucetti, Lidia C</au><au>Atadja, Peter</au><au>Bair, Kenneth W</au><au>Cornell, Wendy D</au><au>Green, Michael A</au><au>Howell, Kobporn Lulu</au><au>Jung, Manfred</au><au>Kwon, Paul</au><au>Trogani, Nancy</au><au>Walker, Heather</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2002-02-14</date><risdate>2002</risdate><volume>45</volume><issue>4</issue><spage>753</spage><epage>757</epage><pages>753-757</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibition assay, a p21waf1 (p21) promoter assay, and in monolayer growth inhibition assays. One compound, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, was found to affect the growth of a panel of eight human tumor cell lines differentially.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>11831887</pmid><doi>10.1021/jm015568c</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2002-02, Vol.45 (4), p.753-757
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_71440914
source MEDLINE; American Chemical Society Journals
subjects Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Benzamides - chemical synthesis
Benzamides - chemistry
Benzamides - pharmacology
Biological and medical sciences
Cyclin-Dependent Kinase Inhibitor p21
Cyclins - metabolism
Drug Screening Assays, Antitumor
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
General aspects
Histone Deacetylase Inhibitors
Humans
Hydroxamic Acids - chemical synthesis
Hydroxamic Acids - chemistry
Hydroxamic Acids - pharmacology
Hydroxylamines - chemical synthesis
Hydroxylamines - chemistry
Hydroxylamines - pharmacology
Medical sciences
Models, Molecular
Pharmacology. Drug treatments
Promoter Regions, Genetic
Structure-Activity Relationship
Tumor Cells, Cultured
title Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A30%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitors%20of%20Human%20Histone%20Deacetylase:%E2%80%89%20Synthesis%20and%20Enzyme%20and%20Cellular%20Activity%20of%20Straight%20Chain%20Hydroxamates&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Remiszewski,%20Stacy%20W&rft.date=2002-02-14&rft.volume=45&rft.issue=4&rft.spage=753&rft.epage=757&rft.pages=753-757&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm015568c&rft_dat=%3Cproquest_cross%3E71440914%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71440914&rft_id=info:pmid/11831887&rfr_iscdi=true